Nature Bioentrepreneur
Nature Biotechnology
Nature Medicine
Nature Reviews Drug Discovery
Governments backing manufacturing to save startups
Universities weigh spin-offs versus licensing patents
Europe fights 'brain drain' with new research grants
Swiss biotech lead linked to sluggish public support
Patenting costs cast a shadow on European biotech
Dutch biotech celebrates late arrivals
FDA's cloning report exposes European dilemma
Liberty Link rice raises specter of tightened regulations
South African GM label confusion
USDA approves the first plant-based vaccine
WTO finds 'undue delay' for GM import in Europe
French court: destroying field trials, a 'necessity'
WTO gives poor states access to drugs
Monsanto joins Greenpeace in opposing EU sperm patent
EU proposal for tissue-engineered products
Saudi Arabia moves into biofuels
US Supreme court strikes against frivolous litigation
Blueprint North America winds down
UN balks on therapeutic cloning; nations forge ahead
Incyte sells proteome databases
UK seeks to relax shareholder preemption rights
EU struggles with rules on therapeutic tissues and cells
Scientists rail against Europe’s absence in AIDS research
Scientists charged with choosing publication over public health
Money, manpower missing from Europe's new agency
Database draws attention to not-so-Nobel intentions
Edible vaccines not ready for main course
Scientists rip US for cutbacks to global AIDS summit
Newly expanded European Union faces growing pains
Europe urged to step up applied cardiovascular research
French researchers face winter of discontent
Halted trial renews questions about cancer vaccines
European Parliament set to ban cloning for transplantation